Phenoxybenzamine Hydrochloride Capsule — FDA Drug Shortage

To Be Discontinued — Advanz Pharma (US) Corp.

The FDA lists a drug shortage record for Phenoxybenzamine Hydrochloride Capsule (capsule) from Advanz Pharma (US) Corp. with status To Be Discontinued. The shortage was first posted on Dec 1, 2025.

Shortage details

Status
To Be Discontinued
Company
Advanz Pharma (US) Corp.
Package NDC
59212-001-02
Dosage Form
Capsule
Presentation
Dibenzyline, Capsule, 10 mg (NDC 59212-001-02)
Initial Posting
Dec 1, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.